Elevated liver enzymes is not an impediment to allopurinol dose escalation: an observational cohort study

May Shuen Tang, Qai Ven Yap, Peter Pak Moon Cheung, Amelia Santosa, Gim Gee Teng

Open source

DOI
10.1002/acr.80157
Published
2026-09-07
Container
Arthritis Care & Research
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acr.80157,
  title = {Elevated liver enzymes is not an impediment to allopurinol dose escalation: an observational cohort study},
  author = {May Shuen Tang and Qai Ven Yap and Peter Pak Moon Cheung and Amelia Santosa and Gim Gee Teng},
  year = {2026},
  journal = {Arthritis Care \& Research},
  doi = {10.1002/acr.80157},
  url = {https://doi.org/10.1002/acr.80157}
}

RIS

TY  - JOUR
TI  - Elevated liver enzymes is not an impediment to allopurinol dose escalation: an observational cohort study
AU  - May Shuen Tang
AU  - Qai Ven Yap
AU  - Peter Pak Moon Cheung
AU  - Amelia Santosa
AU  - Gim Gee Teng
PY  - 2026
JO  - Arthritis Care & Research
DO  - 10.1002/acr.80157
UR  - https://doi.org/10.1002/acr.80157
ER  - 

APA

Tang, M. S., Yap, Q. V., Cheung, P. P. M., Santosa, A., & Teng, G. G. (2026). Elevated liver enzymes is not an impediment to allopurinol dose escalation: an observational cohort study. Arthritis Care & Research. https://doi.org/10.1002/acr.80157

Source records